Aparito was invited to take part in a webinar that discussed digital endpoints by Healx.

Clinical trials often fail due to poor design and / or endpoint selection. These challenges are often amplified in the rare disease field, where substantial patient heterogeneity exists.

In this webinar the evolution of wearable technologies and digital endpoints were discussed, outlining their potential advantages over conventional measurements and monitoring of patients at clinical trial sites.